clinical trials for tirzepatide weight loss trial semaglutide vs. Obesity Semaglutide Safely Improves Metabolic Health – Highlighting 3 ongoing clinical – Other clinical trials with tirzepatide

PlexusDx offers a Precision Peptide Genetic Test that identifies common variants in these peptide-metabolism genes, potentially adding context to a provider conversation about whether standard GLP-1 dosing, microdose protocols, or combination therapies may align better with an individual's genetic profile

Call your clinician, go to the nearest emergency department, or contact your local crisis line

For type 2 diabetes, the recommended starting dose of semaglutide is 0.25 mg once weekly

Mykoniatis I, Tsiakaras S, Samarinas M, Anastasiadis A, Symeonidis EN, Sountoulides P

It is important to recognize that these symptoms do not exist in isolation

A greater proportion of patients randomized to QSYMIA than placebo achieved 5%, 10%, and 15% BMI reduction